METLIFE INC·4

Jun 11, 4:02 PM ET

Harris Carla A 4

4 · METLIFE INC · Filed Jun 11, 2026

Research Summary

AI-generated summary of this filing

Updated

MetLife (MET) Director Carla Harris Receives 42 Shares

What Happened
Carla A. Harris, a director of MetLife, received 42 shares of MetLife common stock on 2026-06-09 at an imputed price of $85.57 per share, for a total value of $3,594. The transaction is reported as an award/acquisition (Code A) and reflects the imputed reinvestment of dividends into deferred shares.

Key Details

  • Transaction date: 2026-06-09; Filing date (Form 4): 2026-06-11.
  • Price per share: $85.57; Shares acquired: 42; Total value: $3,594.
  • Shares owned after transaction: Not disclosed on the Form 4.
  • Footnote: Imputed reinvestment of dividends under the MetLife Deferred Compensation Plan for Non-Management Directors — these are shares that became payable but were deferred (Footnote F1).
  • Timeliness: Filed two days after the transaction (within the standard Form 4 reporting window).

Context
This was a dividend reinvestment into deferred compensation for a non-management director, a routine administrative event rather than an open-market buy or sale. Such awards reflect plan mechanics (dividend deferral) and do not necessarily signal a change in the director’s view on the stock.

Insider Transaction Report

Form 4
Period: 2026-06-09
Transactions
  • Award

    Common Stock

    [F1]
    2026-06-09$85.57/sh+42$3,59410,528 total
Footnotes (1)
  • [F1]Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.
Signature
/s/ Morgan Keehner-Jones Mayes, Attorney-in-fact|2026-06-11

Documents

1 file
  • 4
    wk-form4_1781208145.xmlPrimary

    FORM 4